Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer
PHASE2
This is a randomized, Phase II, double-blind, multicenter, placebo-controll...
A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)
PHASE3
This randomized, multicenter, double-blind, placebo-controlled study will e...
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
PHASE2
This randomized, double-blind, placebo-controlled, multicenter phase II stu...
Status
Completed
Location
University of Alabama At Birmingham; Neuro-Oncology
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer
PHASE2
This multicenter, randomized, double-blind, placebo-controlled study will e...